Advertisement

The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

Lipohypertrophy Symptoms

Here's a taste of what TheBody.com has to offer on this topic:
Connect With Others

Lipodystrophy and Lipohypertrophy

Posted by Bear60
http://www.thebody.com/lipo/overview.html

Its not a difference of weight loss and weight gain.
If you dont know the difference between "wasting" syndrone and lipoatrophy read this. If you think weight gain is a symptom of lipohypertrophy, then read... Read more »

Quick Questions About Lipohypertrophy

Posted by Choosing2Liv, 4 Replies
I faithfully work out three days a week and run at least a couple of miles the other four days. However, I seem to be gaining an unusual amount of weight. :(

A while back, someone used the term "lipohypertrophy" when discussing weight gain, so I... Read more »

Egrifta tesamorelin, is it available?

Posted by artnut, 2 Replies
Positively Aware has an article (July/August 2010)on the FDA approving Egrifta for the treatment of belly fat. Is it available? Has anyone had any experience with it? The biggest problem seems injecting oneself. How about blood sugar levels? ... Read more »
Ask the Experts

Lipohypertrophy Update

Is there any relief for those of us experiencing Lipohypertrophy? I was wondering if there was any update from the Mexico conference.Thanks!...
Nelson Vergel, B.S.Ch.E., M.B.A.

Response from Nelson Vergel, B.S.Ch.E., M.B.A.

Program for Wellness Restoration
I will be providing a summary of the findings of the upcoming Lipodystrophy Conf on Nov 5 here at thebody.com, so stay tuned!Nelson... Read more »

Testosterone and Lipohypertrophy

Dr. Henry......I am currently taking Videx, Viread, Reyataz and Norvir which resulted in lipohypertrophy problems, especially in my stomach in addition to weight gain (about 20 lbs. I have become resistant to Sustiva and Viramune.) I am also...
Keith Henry, M.D.

Response from Keith Henry, M.D.

University of Minnesota, School of Medicine
Contrary to popular perception, use of testosterone has not been shown to decrease lipohypertrophy and may actually aggravate fat loss from the skin so use of testosterone cannot be generally recommended for management of fat distribution problems... Read more »

Treatment for Lipohypertrophy

I am dealing with a case of lipohypertrophy. It seems like whenever I research lipodystrophy, everything is about lipoatrophy and nothing about lipohypertrophy. It is very upsetting, especially since this occurred because I WAS taking my meds like...
Nelson Vergel, B.S.Ch.E., M.B.A.

Response from Nelson Vergel, B.S.Ch.E., M.B.A.

Program for Wellness Restoration
We are waiting for the FDA to potentially approve Egrifta (tesamorelin), which is a daily subcutaneous injection of growth hormone releasing hormone that makes your body make your own growth hormone. It can decrease visceral fat by 15% in 26 weeks.... Read more »

LIPOHYPERTROPHY

is excessive fat growth, and thats what i am having right now after being on ARV treatment for 6 months. Ive been on TRUVADA 6 months and started together with EFAVIRENZ and then switched to REYATAZ and NORVIR the last 2 months. I am now...
Keith Henry, M.D.

Response from Keith Henry, M.D.

University of Minnesota, School of Medicine
I recommend discussing your concerns with your HIV provider to make an assessment as to what could be contributing to your stomach problems. In occasional cases (<<5%) patients may have more significant intraabdominal fat increases that can be... Read more »
Articles
TheBody.com

A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy)

For years now, it has been clear that HIV-positive people are especially prone to developing unusual increases of fat in specific parts of their bodies. What has been less clear is exactly what a person with this type of fat gain, known as... Read more »
HIV i-Base

HIV and the Brain: Longitudinal Results From CHARTER and Other Studies

Table of Contents Asymptomatic Neurocognitive Impairment (ANI) Is Associated With Worse Functional Outcomes Longitudinal Study Examining Neurocognitive Impairment Biomarkers for Predicting Neurocognitive Performance Role of Central Obesity... Read more »
Project Inform

Lipodystrophy and Women

Of all the unintended effects from taking anti-HIV therapy, perhaps none is more visible than lipodystrophy. Lipodystrophy can diminish a person's physical and emotional well-being, leading to an increased risk of heart disease, diabetes and... Read more »
Canadian AIDS Treatment Information Exchange

Maraviroc + Raltegravir: Caution Needed

Researchers in France conducted an exploratory study with 44 HIV-positive participants. Their average age was 55 years and they had been taking ART for 15 years. For the five years prior to the study, their viral loads were less than 50 copies/ml. ... Read more »